7Hache C, Villeneuve JP. Lamivudine treatment in patients with chronic hepatitis B and cirrhosis[ J]. Expert Opin Pharmacother, 2006,7 ( 13 ) : 1835 - 1843.
8Kazuaki C, Yoshiyuki S, Masahiro K, et al. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamvudine therapy and re-takeover by wild type after cessation of therapy [ J ]. Hepatology, 1998,27 : 1711 - 1716.
9Zollner B, Sterneck M, Wursthom K, et al. Prevalence, incidence, and clinical relevance of the reverse transcriptase V207I mutation outside the YMDD motif of the hepatitis B virus polymerase during lamivudine therapy [ J ]. J Clin Microbiol, 2005,43 ( 5 ) : 2503 - 2505.
10Daryl T, IJau Y, Everhart J, et al. Identification and characterization of mutations in HBV resistant to lamivudine [ J ]. Hepatology, 1998,27 : 1670 - 1677.
